NCT00353158View on ClinicalTrials.gov

A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

May 25, 2007

Primary Completion Date

September 20, 2011

Study Completion Date

September 20, 2011

Conditions
Healthy VolunteersFungal InfectionsBacterial Infections
Interventions
DRUG

Doxycycline

100mg twice daily for 3 days. Two hours after the last dose of doxycycline is taken in the clinic, on-medication phototesting with ssUVR, UVA, and visible light will be performed.

DRUG

Voriconazole

After taking voriconazole for (Bullet)7 days to achieve a steady state of voriconazole for subjects, on-medication phototesting with ssUVR, UVA, and visible light will be performed.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

NCT00353158 - A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity | Biotech Hunter | Biotech Hunter